Literature DB >> 12713847

Assessment of the sequence dependency for the binding of 2-aminonaphthyridine to the guanine bulge.

Kazuhiko Nakatani1, Souta Horie, Takashi Murase, Shinya Hagihara, Isao Saito.   

Abstract

We have studied the sequence dependent binding of 2-amino-1,8-naphthyridine derivative 1 to a single guanine bulge. The free energy changes for the binding to a guanine bulge with different sequence contexts (5'X_Y3'/3'X'GY'5') were determined by a curve fitting of the thermal denaturation profile of DNA in the presence and absence of 1. The data showed that (i) the binding of 1 to a guanine bulge is stronger for those flanking the G-C base pair than A-T base pair, (ii) the guanine 3' side to 1 in the complex is especially effective for the complex stabilization, and (iii) the increase of T(m) in the presence of 1 is not a good estimate for the sequence dependent binding. The most efficient 1-binding was observed for the sequence of G_G/CGC. Molecular modeling simulations suggested that stacking interaction between the 3' side guanine and 1 is the molecular basis for the strong binding to G_G/CGC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713847     DOI: 10.1016/s0968-0896(03)00026-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Investigating the binding mode of an inhibitor of the MBNL1·RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder.

Authors:  Chun-Ho Wong; Stacie L Richardson; Yen-Jun Ho; Alex M H Lucas; Tiziano Tuccinardi; Anne M Baranger; Steven C Zimmerman
Journal:  Chembiochem       Date:  2012-10-24       Impact factor: 3.164

2.  Detection of guanine-adenine mismatches by surface plasmon resonance sensor carrying naphthyridine-azaquinolone hybrid on the surface.

Authors:  Shinya Hagihara; Hiroyuki Kumasawa; Yuki Goto; Gosuke Hayashi; Akio Kobori; Isao Saito; Kazuhiko Nakatani
Journal:  Nucleic Acids Res       Date:  2004-01-09       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.